Prestige Consumer Healthcare (FRA:PBV) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PBV Prestige Consumer Healthcare Inc FRA:PBV
72 GF Score
Price €42.20
GF Value €59.76
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Prestige Consumer Healthcare FFO per Share?

FFO per Share only applies to REITs.

FRA:PBV
72GF Score
Prestige Consumer Healthcare Inc FRA:PBV
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Prestige Consumer Healthcare (FRA:PBV) Overvalued in 2026?

Based on GuruFocus' analysis, Prestige Consumer Healthcare stock appears to be undervalued. The current stock price of €42.20 is trading 29.4% below its estimated GF Value™ of €59.76. GuruFocus considers Prestige Consumer Healthcare to be Modestly Undervalued.

Key valuation signals for FRA:PBV:

  • FFO per Share:
  • GF Value™: €59.76 vs. price of €42.20 (29.4% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the FRA:PBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prestige Consumer Healthcare Business Description

Other Exchanges PBH:USA
Address 660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
72GF Score

Get the complete analysis for FRA:PBV

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.20
Price
€59.76
GF Value